These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32449739)

  • 1. Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes.
    Liu Y; Liang Y; Wang M; Wang C; Wei H; Naruse K; Takahashi K
    J Vis Exp; 2020 May; (159):. PubMed ID: 32449739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a model of ischemic heart disease using cardiomyocytes differentiated from human induced pluripotent stem cells.
    Wei H; Wang C; Guo R; Takahashi K; Naruse K
    Biochem Biophys Res Commun; 2019 Dec; 520(3):600-605. PubMed ID: 31623826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speckle-Tracking Strain Analysis for Mapping Spatiotemporal Contractility of Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes.
    Izadifar M; Berecz T; Li B; Tang JKKY; Foldes G; Apati A; Nagy A
    Curr Protoc; 2023 Sep; 3(9):e889. PubMed ID: 37747346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype.
    Yokoyama J; Miyagawa S; Akagi T; Akashi M; Sawa Y
    PLoS One; 2021; 16(3):e0245571. PubMed ID: 33720933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model.
    Kawamura M; Miyagawa S; Fukushima S; Saito A; Miki K; Funakoshi S; Yoshida Y; Yamanaka S; Shimizu T; Okano T; Daimon T; Toda K; Sawa Y
    Sci Rep; 2017 Aug; 7(1):8824. PubMed ID: 28821761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes.
    Davis J; Chouman A; Creech J; Monteiro da Rocha A; Ponce-Balbuena D; Jimenez Vazquez EN; Nichols R; Lozhkin A; Madamanchi NR; Campbell KF; Herron TJ
    JCI Insight; 2021 May; 6(10):. PubMed ID: 33878037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac safety assessment with motion field imaging analysis of human iPS cell-derived cardiomyocytes is improved by an integrated evaluation with cardiac ion channel profiling.
    Isobe T; Honda M; Komatsu R; Tabo M
    J Toxicol Sci; 2019; 44(12):859-870. PubMed ID: 31813905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission.
    Canfield SG; Zaja I; Godshaw B; Twaroski D; Bai X; Bosnjak ZJ
    Anesth Analg; 2016 May; 122(5):1269-79. PubMed ID: 26991754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation.
    Brodarac A; Šarić T; Oberwallner B; Mahmoodzadeh S; Neef K; Albrecht J; Burkert K; Oliverio M; Nguemo F; Choi YH; Neiss WF; Morano I; Hescheler J; Stamm C
    Stem Cell Res Ther; 2015 Apr; 6(1):83. PubMed ID: 25900017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility.
    Blazeski A; Zhu R; Hunter DW; Weinberg SH; Zambidis ET; Tung L
    Prog Biophys Mol Biol; 2012; 110(2-3):166-77. PubMed ID: 22971665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes.
    Pointon A; Harmer AR; Dale IL; Abi-Gerges N; Bowes J; Pollard C; Garside H
    Toxicol Sci; 2015 Apr; 144(2):227-37. PubMed ID: 25538221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-derived Cardiomyocyte Sheets to Improve Cardiac Function in a Primate Ischemic Cardiomyopathy Model.
    Kashiyama N; Miyagawa S; Fukushima S; Kawamura T; Kawamura A; Yoshida S; Eiraku S; Harada A; Matsunaga K; Watabe T; Toda K; Hatazawa J; Sawa Y
    Transplantation; 2019 Aug; 103(8):1582-1590. PubMed ID: 31107828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology.
    Hayakawa T; Kunihiro T; Ando T; Kobayashi S; Matsui E; Yada H; Kanda Y; Kurokawa J; Furukawa T
    J Mol Cell Cardiol; 2014 Dec; 77():178-91. PubMed ID: 25257913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts.
    Kadota S; Pabon L; Reinecke H; Murry CE
    Stem Cell Reports; 2017 Feb; 8(2):278-289. PubMed ID: 28065644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human induced pluripotent stem cell-based platform for modeling cardiac ischemia.
    Häkli M; Kreutzer J; Mäki AJ; Välimäki H; Lappi H; Huhtala H; Kallio P; Aalto-Setälä K; Pekkanen-Mattila M
    Sci Rep; 2021 Feb; 11(1):4153. PubMed ID: 33603154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conduction and contraction properties of human iPS cell-derived cardiomyocytes: analysis by motion field imaging compared with the guinea-pig isolated heart model.
    Isobe T; Honda M; Komatsu R; Tabo M
    J Toxicol Sci; 2018; 43(8):493-506. PubMed ID: 30078835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.